Medicines

HIV/AIDS price information services

WHO, UNAIDS, UNICEF, and MsF partnership

"Sources and Prices of Selected Medicines and Diagnostics for People Living with HIV/AIDS", June 2005, on finished products of selected HIV-related medicines and diagnostics. Includes over 90 active ingredients in 166 dosage forms, and 36 different HIV test kits, issued annually, available as a printed document and on web sites of all partners (UNICEF, UNAIDS, and MSF). This joint project on sources and indicative prices started in 1999; first year publication in 2000. This endeavour will be closely linked with prequalification project managed by WHO.

The report of June 2005 includes updated prices of pharmaceutical products and diagnostic tests. Apart from anti-retroviral medicines, it includes medicines used to treat a range of opportunistic infections, for pain relief, for use in palliative care, for the treatment of AIDS-related cancers and for the management of drug dependence. It also provides information on a range of HIV/AIDS test kits for initial diagnosis of the infection, and ongoing monitoring of antiretroviral treatment and drug resistance.

The report has also a section on registration status of products and information about registered products per country which is available on CD-ROM in the report. The eighth edition of an MSF document, "Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries" June 2005, is included in the report and informs the reader about current discount prices offered by pharmaceutical companies.

Efforts of Latin America and the Caribbean toward the universal access

The WHO Regional office of the Americas provides information about the Latin America and Caribbean efforts to expand access to antiretrovirals. Among the highlights are the three subregional negotiations (Caribbean, Central America and 10 Latin American countries), in which the ministries of health, with the support of PAHO, UNAIDS and other organizations, managed to substantially reduce the price of these medicines. In addition, this web site provides several tools useful to expand access to ARV, such as protocols, lists of drug manufacturers of acceptable quality, recommendations on procurement and an overview of relevant policies and legislation.

Antiretroviral prices agreed in the negotiations of the 10 Latin American countries (June 2003):

The prices of the antiretroviral drugs in the list below were obtained after negotiations between the Ministers of Health of the participating countries and the pharmaceutical companies that manufacture these drugs. In addition to the prices set, the list includes the names of the laboratories that participated in each of the negotiations, the products that were the object of the negotiations (with the brand name and the generic name for companies that manufacture original products, or the designation “generic” for companies that produce generics), the dose in milligrams, and the dosage form of the unit negotiated (1 June 2003).

Reagent Prices Established in the Negotiations of the 10 Latin American Countries: The prices of the reagents used in HIV/AIDS care in the list below were obtained after negotiations between the Ministers of Health of the participating countries and the companies that manufacture these reagents

Médecins sans Frontières (MSF) - Guide on ARV prices

The data in this guide on ARV prices offered by originator companies and some generic companies in low- and middle-income countries are meant to provide potential buyers with clear verified data. This information is intended for use by government and non-profit procurement agencies, as well as other bulk purchasers of ARVs, including health facilities and non governmental organizations (NGOs). Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries.

Share